Express Scripts is one of the largest pharmacy benefit managers in the country; there are 25 million Americans are on its National Preferred Formulary. In order decrease costs, they have decided to remove Epogen, Aranesp, and 23 other products from their list of preferred drugs for 2015. The reason being that the drugs are ones that do not preform well enough to justify their price. According to a statement from the company, less than 0.2 percent of their customers will be affected by this change. They say these changes will ultimately cut the co-pays for patients. How do you see this change affecting the patients in your community?
Find out more from Reuters